Virtual Tumor Board: Targeting Residual Disease Podcast
Podcast | English | 2025 | 49 Min
Image For Activity Cover
Cost
$0.00
Credit
No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Mara Antonoff, Dr. Shankar Siva, and Dr. David Carbone. The case explores the role of ablative therapy for residual disease in patients with stage IV NSCLC.

Podcast Hosts:
  • Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA 

Podcast Guests: 

  • Mara Antonoff, MD, FACS, Associate Professor and Program Director of Education, Thoracic and Cardiovascular Surgery, UT MD Anderson Cancer Center, Houston, TX, USA
  • David Carbone, MD, PhD, Thoracic Medical Oncologist, Director,  James Thoracic Center, Barbara J. Bonner Chair in Lung Cancer Research, Ohio State University, Columbus, OH, USA
  • Professor Shankar Siva, PdH, MBBS, Department of Radiation Oncologist, Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia
Powered By